do you know, are kids getting tested whenever they need it at this point?
i see things like @vermes82 post about finland’s kids, and i wonder how is it not like that here in the states?
6 Likes
Can’t speak for everywhere, we test very liberally here.
11 Likes
My last test (January) cost me $125. I expect that might put a damper on things in AZ.
10 Likes
I read that there are a lot of teens, children and even babies at hospital with Covid. It is very serious and sad.
16 Likes
More reasons to not credit Trump’s “Operation Less Than Bare Minimum”: a litany of bad decisions, incompetence, disinterest, insufficient funding all topped with murderous lies suddenly reversed (well, all but the last part) with the flip of a switch on January 20th.
19 Likes
That seems to be the standard cost, not based on anything other than some kind of agreement between providers. Health insurance ought to pay for the test if it is taken for health reasons (and not just travel). Kaiser even pays for the test if you take it for travel.
7 Likes
That was after insurance (which considered it “out-of-network”).
9 Likes
FFS. We’re fighting a pandemic here, there should be no/zero/zilch impediments to testing. This makes me even more impressed with Kaiser, they’ll pay even if you take the test at a Walgreens (or wherever) instead of at a Kaiser clinic.
10 Likes
Yeah, I miss Kaiser. People’s experiences with them seem to differ based on where they are, but in SF I thought they were great.
6 Likes
The thing I can’t wrap my head around is that we’re still doing better at getting shots into people’s arms than most of Europe (I think everywhere except the UK).
Depressing graph here:
7 Likes
6 Likes
“implies?” So now we just ignore straight up history? Unless there is a “China made it to kill us all” vibe going on, yes, it arose in China.
15 Likes
No numbers? 250 % increase, but how many?
I hate this kind of reports. They leave me afraid, without providing perspective.
That’s not directed at you, mind. Glad to hear from Finland.
4 Likes
I can’t tell if this should go in the COVID thread or in the Assholes thread…
Direct quote from Frank A. D’Amelio, Pfizer’s CFO & Executive VP of Global Supply:
So in terms of, I’ll call it, the business going forward, although we’re not certain, based on everything we’ve seen to date, we believe it’s becoming increasingly likely that an annual revaccination is going to take place. And we believe that, that’s going to take place for the foreseeable future, most likely a single dose, but that’s what we see based on what we’ve seen to date. And not as – so we don’t see this as a onetime event, but we see this as something that’s going to continue for the foreseeable future.
Now in terms of pricing, let me see if I can hit on that. So if you look at how current demand and current pricing is being driven, it’s clearly not being driven by what I’ll call normal market conditions, normal market forces. It’s really been driven by kind of the pandemic state that we’ve been in and the needs of governments to really secure doses from the various vaccine suppliers. So what we believe, what I believe is as we move from a pandemic state, from a pandemic situation to an endemic situation, normal market forces, normal market conditions will start to kick in. And factors like efficacy, booster ability, clinical utility will basically become very important, and we view that as, quite frankly, a significant opportunity for our vaccine from a demand perspective, from a pricing perspective, given the clinical profile of our vaccine. So clearly, more to come here. But we think as this shifts from pandemic to endemic, we think there’s an opportunity here for us.
22 Likes
Nothing like trying to shake the “Pharma Vampire” reputation, eh? Yeah, nicely done.
19 Likes
The cost:
Now multiply…
9 Likes
Pfizer’s going to Pfizer. The wild card is Moderna. They aren’t driven by the same Big Pharma mentality by default. If Moderna keeps their vaccine boosters affordable, Pfizer may be forced to follow suit.
13 Likes
Unless they change the “no mix and match” rule, Pfizer has a captive market. They are not doing themselves any favors, though.
9 Likes
7 Likes
They’re shaking it right now!
10 Likes
